Kim Seong-sun, head of the business division of Medi-I Plus (CEO Ji-hee Jeong), announced on the 1st that at the '2025 K Med Expo & Hanoi Int'l Meditech Show' held at the ICE Exhibition Center in Hanoi, Vietnam on July 11th, they signed a business agreement (MOU) for global clinical trial cooperation with Thang Long Institute of Medical and Pharmaceutical Research (hereinafter referred to as IMP), a clinical trial contract research organization (CRO) under the Ministry of Science and Technology of Vietnam.
IMP is a leading CRO conducting clinical trials for pharmaceuticals and medical devices in Vietnam, with extensive experience collaborating with numerous global pharmaceutical companies. Through this agreement, both parties plan to collaborate in various areas, including expanding their clinical trial network, matching global partners based on the FiCRO platform, and enhancing the data-driven clinical trial environment.
MediiPlus provides AI-based clinical trial innovation solutions. Through its FiCRO platform, it helps pharmaceutical, bio, and medical device companies quickly find the optimal CRO. Currently, it collaborates with over 200 institutions domestically and internationally, building a global network that enhances clinical trial efficiency.
An IMP official said, “We have experienced limitations in matching with global clients, but we expect that Mediplus’ FiCRO platform will be able to solve this problem,” and “Through this collaboration, we will be able to strengthen our connection opportunities with global pharmaceutical companies as well as those in Vietnam.”
“This agreement will be a significant turning point in the expansion of clinical trial infrastructure in Southeast Asia,” said Kim Seong-sun, head of Mediiplus. “Through the FiCRO platform, we will strengthen the connection between global sponsors and Vietnamese CROs and work to accelerate healthcare innovation in both countries.”
Furthermore, MediPlus plans to lower the barriers to entry into global clinical trials by introducing additional services such as researcher matching, regulatory forecasting, and optimization to the FiCRO platform, and to establish itself as a central hub of the global clinical trial ecosystem that innovates the clinical trial preparation process through data-driven CRO matching.
- See more related articles
You must be logged in to post a comment.